Even if they’re not acquired, these small companies are developing promising obesity and diabetes treatments.
Big pharma is looking to fatten profits with buyouts of weight-loss drug companies. Here are 4 candidates.
Read Next
- CFPB expands oversight of Apple Pay, other digital payments services
- LiquidityBook completes SOC 1 Type 1 and SOC 2 Type 1 audits
- Harnessing AI for Neuroscience: IIT Madras and NVIDIA’s Innovative Approach
- International Criminal Court issues arrest warrants for Netanyahu and Hamas officials
- RBI purchases $9.6 billion in September to curb rupee’s appreciation amid Fed rate cut buzz, ET BFSI
- Asian Development Bank to provide $4.25 billion to Tata Power for clean energy power projects, ET BFSI
- SEC charges Touzi Capital in connection with $115M securities offering fraud
